Ketamine as an Adjuvant for Treatment of Cancer Pain in Children and Adolescents

Journal of Pain

Volumn 8, Issue 6, 2007, Pages 515-521

  Finkel, Julia C ^a   Pestieau, Sophie R ^a   Quezado, Zenaide M N ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

cancer pain; children; hyperalgesia; Ketamine; opioid; pediatric; tolerance

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; HYDROMORPHONE; KETAMINE; LORAZEPAM; METHADONE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE;

ADJUVANT THERAPY; ADOLESCENT; ARTICLE; CANCER PAIN; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG ANTAGONISM; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HALLUCINATION; HUMAN; HYPERALGESIA; MALE; MYDRIASIS; MYOCLONUS; MYOCLONUS SEIZURE; NOCICEPTION; PAIN THRESHOLD; RESPIRATION DEPRESSION; SCHOOL CHILD; SEDATION; SIDE EFFECT;

ADOLESCENT; AGE FACTORS; ANALGESICS, OPIOID; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; HYPERALGESIA; INJECTIONS, INTRAVENOUS; KETAMINE; MALE; NEOPLASMS; PAIN THRESHOLD; PAIN, INTRACTABLE; PATIENT SATISFACTION; QUALITY OF LIFE; RECEPTORS, N-METHYL-D-ASPARTATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34249774882     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2007.02.429     Document Type: Article

References (37)

1. Angst M.S., and Clark J.D. Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology 104 (2006) 570-587
2. Bell R.F., Eccleston C., and Kalso E. Ketamine as adjuvant to opioids for cancer pain: A qualitative systematic review. J Pain Symptom Manage 26 (2003) 867-875
3. Berde C.B., and Sethna N.F. Analgesics for the treatment of pain in children. N Engl J Med 347 (2002) 1094-1103
4. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., and Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47 (2000) 351-354
5. Celerier E., Laulin J.P., Corcuff J.B., Le Moal M., and Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization process. J Neurosci 21 (2001) 4074-4080
6. Celerier E., Rivat C., Jun Y., Laulin J.P., Larcher A., Reynier P., and Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine. Anesthesiology 92 (2000) 465-472
7. Chen L., and Huang L.Y. Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 356 (1992) 521-523
8. Collins J.J., Geake J., Grier H.E., Houck C.S., Thaler H.T., Weinstein H.J., Twum-Danso N.Y., and Berde C.B. Patient-controlled analgesia for mucositis pain in children: A three-period crossover study comparing morphine and hydromorphone. J Pediatr 129 (1996) 722-728
9. Collins J.J., Grier H.E., Kinney H.C., and Berde C.B. Control of severe pain in children with terminal malignancy. J Pediatr 126 (1995) 653-657
10. Drake R., Longworth J., and Collins J.J. Opioid rotation in children with cancer. J Palliat Med 7 (2004) 419-422
11. Elia N., and Tramer M.R. Ketamine and postoperative pain: A quantitative systematic review of randomised trials. Pain 113 (2005) 61-70
12. Hansen G., Jensen S.B., Chandresh L., and Hilden T. The psychotropic effect of ketamine. J Psychoactive Drugs 20 (1988) 419-425
13. Hocking G., and Cousins M.J. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 97 (2003) 1730-1739
14. Hurwitz C.A., Duncan J., and Wolfe J. Caring for the child with cancer at the close of life: "There are people who make it, and I'm hoping I'm one of them. " JAMA 292 (2004) 2141-2149
15. Jalmsell L., Kreicbergs U., Onelov E., Steineck G., and Henter J.I. Symptoms affecting children with malignancies during the last month of life: A nationwide follow-up. Pediatrics 117 (2006) 1314-1320
16. Joly V., Richebe P., Guignard B., Fletcher D., Maurette P., Sessler D.I., and Chauvin M. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 103 (2005) 147-155
17. Kissin I., Bright C.A., and Bradley Jr. E.L. The effect of ketamine on opioid-induced acute tolerance: Can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations?. Anesth Analg 91 (2000) 1483-1488
18. Klepstad P., Borchgrevink P., Hval B., Flaat S., and Kaasa S. Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor. J Pediatr Hematol Oncol 23 (2001) 616-619
19. Larcher A., Laulin J.P., Celerier E., Le Moal M., and Simonnet G. Acute tolerance associated with a single opiate administration: Involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 84 (1998) 583-589
20. Laulin J.P., Celerier E., Larcher A., Le Moal M., and Simonnet G. Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89 (1999) 631-636
21. Laulin J.P., Larcher A., Celerier E., Le Moal M., and Simonnet G. Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur J Neurosci 10 (1998) 782-785
22. Luginbuhl M., Gerber A., Schnider T.W., Petersen-Felix S., Arendt-Nielsen L., and Curatolo M. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg 96 (2003) 726-732
23. Menigaux C., Fletcher D., Dupont X., Guignard B., Guirimand F., and Chauvin M. The benefits of intraoperative small-dose ketamine on postoperative pain after anterior cruciate ligament repair. Anesth Analg 90 (2000) 129-135
24. Mercadante S. Opioid rotation for cancer pain: Rationale and clinical aspects. Cancer 86 (1999) 1856-1866
25. Mercadante S., Ferrera P., Villari P., and Arcuri E. Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage 26 (2003) 769-775
26. Mercadante S., Villari P., and Ferrera P. Burst ketamine to reverse opioid tolerance in cancer pain. J Pain Symptom Manage 25 (2003) 302-305
27. Ripamonti C., Groff L., Brunelli C., Polastri D., Stavrakis A., and De Conno F. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio?. J Clin Oncol 16 (1998) 3216-3221
28. Schmid R.L., Sandler A.N., and Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: A review of current techniques and outcomes. Pain 82 (1999) 111-125
29. Sjogren P., Jensen N.H., and Jensen T.S. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain 59 (1994) 313-316
30. Sjogren P., Jonsson T., Jensen N.H., Drenck N.E., and Jensen T.S. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 55 (1993) 93-97
31. Smith M.T. Neuroexcitatory effects of morphine and hydromorphone: Evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 27 (2000) 524-528
32. Suzuki M., Haraguti S., Sugimoto K., Kikutani T., Shimada Y., and Sakamoto A. Low-dose intravenous ketamine potentiates epidural analgesia after thoracotomy. Anesthesiology 105 (2006) 111-119
33. Tiseo P.J., Thaler H.T., Lapin J., Inturrisi C.E., Portenoy R.K., and Foley K.M. Morphine-6-glucuronide concentrations and opioid-related side effects: A survey in cancer patients. Pain 61 (1995) 47-54
34. Tsui B.C., Davies D., Desai S., and Malherbe S. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma. J Pediatr Hematol Oncol 26 (2004) 678-680
35. Wolfe J., Grier H.E., Klar N., Levin S.B., Ellenbogen J.M., Salem-Schatz S., Emanuel E.J., and Weeks J.C. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342 (2000) 326-333
36. Yaksh T.L., and Harty G.J. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J Pharmacol Exp Ther 244 (1988) 501-507
37. Zarate Jr. C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., and Manji H.K. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63 (2006) 856-864